MedPath

合肥源丰顺医药科技有限公司

Ownership
-
Established
2017-01-13
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258083
Approval Date
May 19, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258082
Approval Date
May 19, 2025
NMPA

Fat Emulsion Injection (C14~24)

Product Name
脂肪乳注射液(C14~24)
Approval Number
国药准字H20253189
Approval Date
Jan 14, 2025
NMPA

Fat Emulsion Injection (C14~24)

Product Name
脂肪乳注射液(C14~24)
Approval Number
国药准字H20253188
Approval Date
Jan 14, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20065536
Approval Date
Jun 28, 2021
NMPA

Famotidine Injection

Product Name
法莫替丁注射液
Approval Number
国药准字H20063829
Approval Date
May 6, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.